X-LINKED LYMPHOPROLIFERATIVE SYNDROME

This adverse event was reported 33 times

These drugs are most commonly taken by patients reporting X-LINKED LYMPHOPROLIFERATIVE SYNDROME:

# Drug Count
0 RITUXIMAB 27
1 INFLIXIMAB 25
2 CANAKINUMAB 24
3 COLCHICINE 24
4 MESALAMINE 24
5 TOCILIZUMAB 24
6 VEDOLIZUMAB 24
7 DEXAMETHASONE 3
8 DEXAMETHASONE 1.5 MG 3
9 HUMAN IMMUNOGLOBULIN G 2
See all common drugs associated with X-LINKED LYMPHOPROLIFERATIVE SYNDROME

X-LINKED LYMPHOPROLIFERATIVE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAKINUMAB 24 0.0022
1 COLCHICINE 24 0.0009
2 MESALAMINE 24 0.0009
3 VEDOLIZUMAB 24 0.0003
4 TOCILIZUMAB 24 0.0002
5 RITUXIMAB 27 0.0001
6 VANCOMYCIN HYDROCHLORIDE 1 0.0001
7 INFLIXIMAB 25 0.0001
8 HUMAN IMMUNOGLOBULIN G 2 0.0001
9 PIPERACILLIN AND TAZOBACTAM 1 0.0001
See all drugs enriched for association with X-LINKED LYMPHOPROLIFERATIVE SYNDROME